High thrombin-activatable fibrinolysis inhibitor levels may protect against recurrent fetal loss

H. M. Knol*, N. J. G. M. Veeger, S. Middeldorp, K. Hamulyak, J. Van Der Meer

*Corresponding author for this work

Research output: Contribution to journalLetter (Research letter)Academicpeer-review

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)903-906
Number of pages4
JournalJournal of Thrombosis and Haemostasis
Volume7
Issue number5
DOIs
Publication statusPublished - May-2009

Keywords

  • INCREASED RISK
  • VENOUS THROMBOEMBOLISM
  • ARTERIAL THROMBOSIS
  • NORMAL-PREGNANCY
  • TAFI
  • MUTATION
  • WOMEN

Cite this